Analyst firms · HSBC · ILMN
HSBC ILMN price target and rating history
Illumina Inc. (ILMN) · Health Care
HSBC rates Illumina Inc. (ILMN) Hold with a $100 price target, as of its latest action on Feb 28, 2025. It has published 3 rating actions on ILMN since January 2024, including 1 upgrade and 2 downgrades. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
- Current rating
- Hold
- Price target
- $100
- Median target, all firms
- $185
- Actions on ILMN
- 3
HSBC price target on ILMN
Every HSBC rating on ILMN
- Feb 28, 2025
- Oct 17, 2024
- Jan 16, 2024DowngradeHSBC downgrades to Hold from Buy
How other firms rate ILMN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stephens | Equal-Weight | $275 | Oct 23, 2026 |
| UBS | Buy | $260 | Sep 9, 2026 |
| Bernstein | Mkt Perform | $185 | Jun 26, 2026 |
| RBC Capital Markets | Outperform | $170 | May 15, 2026 |
| Daiwa | Outperform | $155 | May 14, 2026 |
Questions about HSBC and ILMN
- What is HSBC's price target for ILMN?
- HSBC's latest stated price target for Illumina Inc. (ILMN) is $100, from its action on Feb 28, 2025.
- What is HSBC's rating on ILMN?
- HSBC rates ILMN Hold, a neutral rating, as of Feb 28, 2025.
- When did HSBC last change its view on ILMN?
- On Feb 28, 2025, HSBC downgrades to Hold from Buy, price target $100.
- How does HSBC's ILMN target compare with other analysts?
- Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
More ILMN rating histories
All HSBC ratingsILMN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.